Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Treasury Shares (2017 - 2025)

Haemonetics (HAE) has 15 years of Treasury Shares data on record, last reported at $332292.0 in Q4 2025.

  • For Q4 2025, Treasury Shares rose 58.62% year-over-year to $332292.0; the TTM value through Dec 2025 reached $332292.0, up 58.62%, while the annual FY2025 figure was $335843.0, 9.18% down from the prior year.
  • Treasury Shares reached $332292.0 in Q4 2025 per HAE's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.4 million in Q3 2025 and bottomed at $209494.0 in Q4 2024.
  • Average Treasury Shares over 5 years is $530537.6, with a median of $349864.5 recorded in 2025.
  • Peak YoY movement for Treasury Shares: plummeted 83.25% in 2021, then skyrocketed 252.36% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $248463.0 in 2021, then dropped by 15.08% to $211000.0 in 2022, then skyrocketed by 372.51% to $997000.0 in 2023, then crashed by 78.99% to $209494.0 in 2024, then surged by 58.62% to $332292.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $332292.0 in Q4 2025, $1.4 million in Q3 2025, and $363886.0 in Q2 2025.